Category: 3. Business

  • This couple left their jobs to travel 160,000 km across the world in their Land Rover

    This couple left their jobs to travel 160,000 km across the world in their Land Rover

    When 28 year olds Nick Chazee and Mathilde Vougny packed up their belongings to travel the world three years ago, they chose to do it in an unconventional way — in their Land Rover.

    Chazee, who was working at a technology startup, and Vougny at the United Nations, were exposed to frequent work travel. But that did not abate their craving to travel more.

    “Anytime we had free time, we would go around and travel like even if it was five hours away from home,” said Vougny.

    Their passion for travel made them realize that they wanted to do it full-time.

    They thought “wouldn’t it be so cool if we could just keep driving and go to Turkey and then to Central Asia, and then all the way to Singapore… and do the whole world,” said Chazee.

    Financing the trip

    It took the couple nearly two years to save up the money to realize their dreams. Initially, the trip was completely self-funded, according to Chazee.

    It was only after the couple started documenting their travel on social media platforms that they could rely on that income stream to fund their trips.

    “This life is the dream. It’s so much fun, and it’s freedom every day,” said Nick Chazee

    However, the couple admitted that they had not intended to monetize their social media presence at the start.

    “We’re already doing those videos, but it was for friends and family, so there was no pressure,” said Vougny.

    They planned to stop their journey when finances ran out, but “the money started coming when we were doing it not for the money… we’re lucky,” Vougny told CNBC Travel.

    Their expenses typically cover the diesel and maintenance of the car, Wi-Fi, Netflix and music subscriptions, visa, and shipping containers for the car to be transported, totaling an estimate of $41,000 per year.

    The couple saves on utility bills, rent, and avoid hotels, resulting in a lifestyle that is much cheaper than before they started traveling for a living.

    Since Chazee and Vougny need to ship their car whenever they fly to another country, the couple tries to save money by booking flights at the last minute.

    That ensures they never have to reschedule a flight if their shipping plans are derailed, saving them a lot of money as shipment costs typically account for a large portion of their expenses, at an average of $6,000 a year.

    Travelers who book their shipments and flights in advance risk having to rebook their flights with additional costs to accommodate the unpredictable shipping schedule, said Chazee.

    “We literally buy the plane ticket the same day that we want to leave, so we pay maybe 10% more than what it cost two months ago, but at the end, we saved so much more.”

    If shipment ever delayed their car, they continued traveling by motorbike.

    “We don’t take planes usually anywhere, unless… it’s between our car and our motorbike,” said Chazee.

    For this couple, the best experiences are found traveling off the main road

    Nick and Mathilde

    Managing daily routines in their Land Rover

    With a 65-liter water tank refilled at fuel stations, a full-sized shower head, a dual-fuel stove system, and a 45-liter fridge, the vehicle was designed to support daily life on the road.

    Laundry gets done every two weeks either by public laundry machines or through third-party services.  

    The “car setup is perfect in many places, except for the heat,” said Chazee. “We use fans for the night when we sleep… but it’s still too hot sometimes and so we’re sweating. It’s hard to sleep.”

    On the other hand, when temperatures dropped to -15°C in Alaska, “we were inside in T-shirts and shorts because we [had] a diesel heater… [and] the hot shower,” he said.  

    45,000 kilometers traveled a year, half a day is spent driving and the other half doing activities

    Nick and Mathilde

    Bittersweet moments

    In their three years of traveling in a Land Rover, the couple have experienced some rough bumps on the road.

    One of such instances occurred after a draining process of shipping their Land Rover to Australia — a move that cost around $7,000.

    “Five days after we start driving in Australia, the engine breaks down entirely… worst experience possible,” said Vougny.

    After 10 minutes, a local stopped to help.

    “We eventually spent 21 days at his home, he helped us fix the car… we were cooking for them, [and] they were cooking for us,” she said. “So even that I can’t recall as a bad memory, but it would totally qualify as a bad moment for us.”

    Apart from mechanical challenges, being far from family meant that they had to keep their car parked safely abroad while they returned home.

    “But again, we’re lucky because of the community we built online. We have people in every country, and they’re always so welcoming,” said Vougny. “Usually they take really good care of our home, because if they follow our journey, they also know our car very well, and so they care about it as much as we do.”

    Highlights on the road

    The couple has a little tradition — “every time we enter a country, we try to find a local from the country to stick the country flag on our car,” she said.

    When they were camping in Bolivia, Vougny recalled an interaction with an old man who was afraid that they came to steal their llamas.

    “And that was super nice because you know, we tend to be scared of strangers, [yet] he was scared of us… and eventually we talked,” she said. “For me, those small interactions are… my best memories.”

    The car draws its own attention with its French license plate and a left-hand drive steering wheel. “So when we go eat, we usually get a bit of chit chat. You meet people,” she said.

    One of the highlights of their trip across 160,000 kilometers, is that more than 300 people globally have invited the couple to their homes. “I save all of their names and their location, so when we get to these countries, we write to them again,” said Chazee.

    They thought constant travel would wear them out, but it never did, said Vougny.

    Though they are set on ending the trip in two years, there are plans for “a new, bigger vehicle and travel to the continents that we really want to do again, or that we feel like we haven’t seen enough,” he said.

    Another possible plan is setting up a home base to welcome other travelers in the future and “give back… what we received on this trip,” said Vougny.

    Continue Reading

  • Australia news live: Gina Rinehart among beneficiaries of Australia-US deal as rare earth stocks soar | Australia news

    Australia news live: Gina Rinehart among beneficiaries of Australia-US deal as rare earth stocks soar | Australia news

    Critical mineral stocks rocket after Australia-US deal

    Jonathan Barrett

    Resources and industrial companies have enjoyed a sharp lift in their share prices in early trading on the ASX as investors weigh up the new Australian-American $US8.5bn critical minerals deal.

    Anthony Albanese specifically referred to two “priority projects”, one by Alcoa and the other by Arafura Rare Earths, that will enjoy an injection of capital from the government, as part of a broader list of strategic operations.

    Shares in Arafura surged by more than 15% this morning to trade above 55c, while Alcoa was up 8% to $60.

    Arafura is planning on producing the light rare earth oxides, neodymium and praseodymium, which are crucial to the production of magnets, used in everything from wind turbines and medical devices to electric motors and ballistic missile guidance systems.

    Gina Rinehart has a 10% stake in Arufura.

    Gina Rinehart, pictured here in April in Sydney.
    Gina Rinehart, pictured here in April in Sydney. Photograph: Hollie Adams/Reuters

    Alcoa has a proposed gallium plant in Western Australia. Gallium is a strategic metal and essential input in semiconductor manufacturing and the broader defence sector, used in advanced electronic warfare systems.

    Australia’s broader critical minerals sector has been rocketing in recent weeks amid the push by the Australian and US governments to break China’s control over the sector.

    ‘Ready to go’: Trump and Albanese sign multibillion-dollar critical minerals agreement – video

    Share

    Updated at 

    Key events

    Potato supplies lower due to normal constraints, but 2024 conditions had ‘some impact’ on yields, Woolworths says

    Some shoppers have reported limited potato supply on supermarket shelves in recent days. Woolworths says drought conditions late last year has limited some supplies, but said any missing spuds should soon turn up as seasonal transition windows end.

    A Woolies spokesperson said:

    We still have sufficient supply of potatoes for our customers, but drought conditions from late 2024 and frosts earlier this year have had some impacts on growing yields.

    It’s also not unusual to see some supply constraints at this time of the year as we hit seasonal transition windows.

    We expect things to return to normal in the coming weeks as we move to new season supply.

    Photograph: V Chettleburgh/Getty Images
    Share

    Updated at 

    Continue Reading

  • Asian Stocks Rally on Wall Street Earnings Lift: Markets Wrap

    Asian Stocks Rally on Wall Street Earnings Lift: Markets Wrap

    (Bloomberg) — Asian shares rose Tuesday, buoyed by upbeat US earnings and indications that tensions between Washington and Beijing were easing.

    Benchmarks in Japan and Australia climbed with stocks in South Korea jumping over 1% at the open. US equity futures edged higher after the S&P 500 and the Nasdaq 100 both rose more than 1% Monday. A gauge of US-listed Chinese companies advanced 2.4%, its best showing in a week. Gold extended gains in early Asian trading, even as some warned about a potential bubble in the precious metal.

    The S&P 500 logged its biggest two-day gain since June on Monday, with about 85% of companies beating profit estimates so far. Strong third-quarter earnings helped temper worries over the US government shutdown, while hopes of progress in US-China trade talks lifted sentiment. President Donald Trump reiterated his threat to follow through on a tariff hike on Chinese goods “if there isn’t a deal” by Nov. 1, but said he plans to meet President Xi Jinping next week.

    “Thank God for earnings season,” said Callie Cox at Ritholtz Wealth Management. Given the US government shutdown, analysts have been deprived of data for weeks, leading to “panic around headlines,” she said.

    Earlier this month, markets were roiled as Trump raised the prospect of a sky-high tariff rate, citing China’s “hostile” export controls. Soybean futures rallied Monday, with growers holding out hope that Trump will make a deal with China to restart stalled American exports.

    Separately, shares of critical mineral producers jumped in Sydney on Tuesday after Trump signed an agreement with Australian Prime Minister Anthony Albanese to boost America’s access to rare earths and other key materials.

    US Inflation

    After being delayed by the US government shutdown, the Bureau of Labor Statistics will release the September consumer price index on Friday. The data, originally slated for Oct. 15, will give Federal Reserve officials a critical piece of information on inflation ahead of their Oct. 30 meeting.

    Economists in a Bloomberg survey forecast the core CPI, which excludes food and fuel for a better snapshot of underlying inflation, to have climbed 0.3% for a third straight month as higher import duties continue to gradually filter through to consumers. The projected monthly gain will keep the annual core CPI at 3.1%.

    “September core CPI likely moderated slightly due to cooling services prices offsetting additional tariff passthrough into goods prices,” said Oscar Munoz at TD Securities. “Energy prices likely boosted headline CPI.”

    Friday’s inflation data may take on greater importance due to the government shutdown-driven data drought, said Rick Gardner at RGA Investments. He still sees a Fed cut in October and noted that a key test will be big tech earnings, with investors looking for clarity on how spending on artificial intelligence is leading to profitability.

    “We are seeing the typical seasonal volatility in October, but the recent swings have been relatively shallow by historical standards, as the buy-the-dip mentality appears to be in play,” Gardner said.

    Some of the main moves in markets:

    Stocks

    S&P 500 futures were little changed as of 9:16 a.m. Tokyo time Hang Seng futures rose 1.4% Japan’s Topix rose 0.4% Australia’s S&P/ASX 200 rose 0.6% Euro Stoxx 50 futures rose 0.2% Currencies

    The Bloomberg Dollar Spot Index was little changed The euro was little changed at $1.1651 The Japanese yen was little changed at 150.61 per dollar The offshore yuan was little changed at 7.1226 per dollar The Australian dollar was little changed at $0.6518 Cryptocurrencies

    Bitcoin fell 0.7% to $110,323.19 Ether fell 0.7% to $3,971.05 Bonds

    The yield on 10-year Treasuries was unchanged at 3.98% Japan’s 10-year yield declined one basis point to 1.660% Australia’s 10-year yield declined three basis points to 4.12% Commodities

    West Texas Intermediate crude fell 0.1% to $57.45 a barrel Spot gold was little changed This story was produced with the assistance of Bloomberg Automation.

    ©2025 Bloomberg L.P.

    Continue Reading

  • How this Grant Thornton graduate uses AI expertise to open doors – Microsoft Source

    1. How this Grant Thornton graduate uses AI expertise to open doors  Microsoft Source
    2. Australians struggling to recognise AI and scams says Good Things Australia  Mi-3.com.au.
    3. Executives fear AI is making them obsolete  The Australian
    4. Mutual Mentorship and AI for Career Growth: Workplace Lessons According to Gen Z  Women Love Tech
    5. KPMG, PwC surveys find Australians are cautious about AI  Accounting Times

    Continue Reading

  • 2025 APJ eCrime Report: AI Threats, Ransomware & Trends

    2025 APJ eCrime Report: AI Threats, Ransomware & Trends

    Chinese-speaking actors evade government restrictions and solicit criminal services through anonymized marketplaces; AI-accelerated ransomware operations signal next evolution of threats

    AUSTIN, Texas and GovWare 2025, Singapore – October 20, 2025 – CrowdStrike (NASDAQ: CRWD) today released the 2025 APJ eCrime Landscape Report, exposing a thriving Chinese-language underground ecosystem and the rise of AI-enhanced ransomware operations. Despite the Chinese government’s internet restrictions and eCrime crackdown, anonymized marketplaces remain central to cybercrime activity across Asia Pacific and Japan (APJ). This ecosystem provides a safe haven for Chinese-speaking actors to buy and sell stolen credentials, phishing kits, malware, and money-laundering services – processing billions in illicit transactions.

    At the same time, AI is transforming the ransomware economy. From AI-enhanced social engineering to automated malware development, AI is accelerating every stage of the attack chain – representing a new wave of adversaries executing Big Game Hunting campaigns against high-value organizations across APJ.

    APJ eCrime Landscape Report Highlights:

    Based on frontline intelligence from CrowdStrike’s elite threat hunters and intelligence analysts tracking  more than 265 named adversaries, the report reveals:

    • Chinese eCrime Marketplaces Evade Oversight: Amid tightened restrictions, Chinese underground markets — including Chang’an, FreeCity, and Huione Guarantee — preserve anonymity across clearnet, darknet, and Telegram channels. This decentralized ecosystem remains a hub for Chinese-speaking actors focused on operational security (OPSEC), with Huione Guarantee alone processing an estimated $27 billion USD before its 2025 disruption.
    • AI Escalates Big Game Hunting Ransomware Campaigns: AI-accelerated ransomware on high-value targets surged, with India, Australia, and Japan among the most impacted countries. Emerging Ransomware-as-a-Service providers KillSec and Funklocker – leveraging AI-developed malware – accounted for more than 120 incidents. Top targeted sectors included manufacturing, technology, and financial services, with 763 victims publicly named on dedicated leak sites.
    • Chinese-Speaking Actors Exploit Japanese Trading Accounts: Coordinated account takeover (ATO) campaigns targeting Japanese securities platforms compromised users to artificially inflate the value of thinly traded China-based stocks. This pump-and-dump scheme, traced to Chinese-speaking threat actors, used shared phishing infrastructure to sell victim data on underground forums, including Chang’an Marketplace.
    • eCrime Service Providers Industrialize Attacks: Providers such as CDNCLOUD (Bulletproof Hosting), Magical Cat (Phishing-as-a-Service), and Graves International SMS (Global Spam Service) enabled scalable phishing, malware distribution, and monetization operations throughout the region.
    • Remote Access Tools Target Regional Users: Likely Chinese-speaking eCrime actors deployed tools like ChangemeRAT, ElseRAT, and WhiteFoxRAT to exploit Chinese- and Japanese-speaking users through SEO poisoning, malvertising, and phishing attacks masquerading as purchase orders.


    “eCrime actors are industrializing cybercrime across APJ through thriving underground markets and complex ransomware operations. Simultaneously, AI-developed malware enables adversaries to launch high-velocity, high-volume attacks,” said Adam Meyers, head of counter adversary operations at CrowdStrike. “Defenders must meet this new pace of attack with decisive action, powered by AI, informed by human experience, and unified in response.” 

    Download the 2025 APJ eCrime Landscape Report to explore in-depth insights, adversary profiles, and expert strategies for defending against APJ’s evolving cyber threats.

    About CrowdStrike

    CrowdStrike (NASDAQ: CRWD), a global cybersecurity leader, has redefined modern security with the world’s most advanced cloud-native platform for protecting critical areas of enterprise risk – endpoints and cloud workloads, identity and data.

    Powered by the CrowdStrike Security Cloud and world-class AI, the CrowdStrike Falcon® platform leverages real-time indicators of attack, threat intelligence, evolving adversary tradecraft and enriched telemetry from across the enterprise to deliver hyper-accurate detections, automated protection and remediation, elite threat hunting and prioritized observability of vulnerabilities.

    Purpose-built in the cloud with a single lightweight-agent architecture, the Falcon platform delivers rapid and scalable deployment, superior protection and performance, reduced complexity and immediate time-to-value.

    CrowdStrike: We stop breaches.

    Learn more: https://www.crowdstrike.com/

    Follow us: Blog | X | LinkedIn | Instagram

    Start a free trial today: https://www.crowdstrike.com/trial

    © 2025 CrowdStrike, Inc. All rights reserved. CrowdStrike and CrowdStrike Falcon are marks owned by CrowdStrike, Inc. and are registered in the United States and other countries. CrowdStrike owns other trademarks and service marks and may use the brands of third parties to identify their products and services.

    Media Contact

    Jake Schuster

    CrowdStrike Corporate Communications

    press@crowdstrike.com



    Continue Reading

  • Early-stage economic analysis is increasingly valuable for ACCC merger notifications

    Early-stage economic analysis is increasingly valuable for ACCC merger notifications

    The changes to Australia’s merger notification regime substantially expand the scope for early-stage economic analysis to support more effective and efficient filings.

    The changes to Australia’s merger notification regime substantially expand the scope for early-stage economic analysis to support more effective and efficient filings for merging parties and their legal advisers. Economic analysis can help determine whether filings are necessary, that filings contain only the required level of detail, and that the economic data and analysis required for filings is complete, accurate, and helpful to the Australian Competition and Consumer Commission (ACCC).

    In this brief, Mark Chicu, Nikhil Gupta, Kostis Hatzitaskos, Avigail Kifer, and Andrew Swan identify areas where early-stage economic analysis is likely to be particularly valuable in navigating the new notification process.

    Continue Reading

  • Shionogi Presents Real-World and Surveillance Data Reinforcing Role of Cefiderocol Across Range of Patient Populations and Difficult-to-Treat Infections| SHIONOGI

    Antimicrobial Resistance

    AMR is a major health burden that urgently needs to be addressed.11 Globally, in 2021, there were 1.14 million deaths attributable to bacterial AMR.13 Infections caused by carbapenem-resistant Gram-negative bacteria are often associated with a high mortality rate.14 If no action is taken, drug-resistant pathogens could cause more than 39 million deaths over the next 25 years.13

     

    About Shionogi in AMR

    Shionogi has a strong heritage in the field of anti-infectives and has been developing antimicrobial therapies for more than 60 years. Shionogi is proud to be one of the few large pharmaceutical companies that continues to focus on R&D in anti-infectives.

     

    About Cefiderocol

    In the U.S., cefiderocol is commercially available under the brand name Fetroja® and is indicated in patients 18 years of age or older for the treatment of hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia and complicated urinary tract infections caused by certain susceptible Gram-negative microorganisms.6 In Europe, cefiderocol is commercially available under the brand name Fetcroja® for the treatment of infections due to aerobic Gram-negative organisms in adults with limited treatment options.15 In Japan, cefiderocol is commercially available under the brand name Fetroja® and received manufacturing and marketing approval from the Ministry of Health, Labour and Welfare for various infections caused by strains resistant to carbapenem antibiotics among sensitive strains of Escherichia coli, Citrobacter species, Klebsiella pneumoniae, Enterobacter species, Serratia marcescens, Proteus species, Morganella morganii, Pseudomonas aeruginosa, Burkholderia species, Stenotrophomonas maltophilia, and Acinetobacter species.

     

    U.S. INDICATIONS

    Fetroja® (cefiderocol) is indicated in patients 18 years of age or older for the treatment of complicated urinary tract infections (cUTIs), including pyelonephritis caused by the following susceptible Gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Enterobacter cloacae complex.

     

    Fetroja is indicated in patients 18 years of age or older for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP), caused by the following susceptible Gram-negative microorganisms: Acinetobacter baumannii complex, Escherichia coli, Enterobacter cloacae complex, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Serratia marcescens.

     

    USAGE

    To reduce the development of drug-resistant bacteria and maintain the effectiveness of Fetroja and other antibacterial drugs, Fetroja should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

     

    IMPORTANT SAFETY INFORMATION

    CONTRAINDICATIONS

    Fetroja is contraindicated in patients with a known history of severe hypersensitivity to cefiderocol or other beta-lactam antibacterial drugs, or any other component of Fetroja.

     

    WARNINGS AND PRECAUTIONS

    Increase in All-Cause Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacterial Infections

    An increase in 28-day all-cause mortality was observed in Fetroja-treated nosocomial pneumonia, bloodstream infections, or sepsis patients compared to those treated with best available therapy (BAT) in a clinical study (NCT02714595). Most BAT regimens contained colistin. All-cause mortality remained higher in patients treated with Fetroja than in patients treated with BAT through Day 49.

     

    Generally, deaths were in patients with infections caused by Gram-negative organisms, including non-fermenters such as Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Pseudomonas aeruginosa, and were the result of worsening or complications of infection, or underlying comorbidities. The cause of the increase in mortality has not been established. Closely monitor the clinical response to therapy in patients with cUTI and HABP/VABP.

     

    Hypersensitivity Reactions

    Serious and occasionally fatal hypersensitivity (anaphylactic) reactions and serious skin reactions have been reported in patients receiving beta-lactam antibacterial drugs. Hypersensitivity was observed with Fetroja. Before Fetroja is instituted, inquire about previous hypersensitivity to cephalosporins, penicillins, or other beta-lactam drugs. If an allergic reaction occurs, discontinue Fetroja.

     

    Clostridioides difficile-associated Diarrhea (CDAD)

    CDAD has been reported with nearly all systemic antibacterial agents, including Fetroja. Careful medical history is necessary because CDAD has been reported to occur more than 2 months after the administration of antibacterial agents. If CDAD is suspected or confirmed, antibacterial drugs not directed against C. difficile may need to be discontinued.

     

    Seizures and Other Central Nervous System (CNS) Adverse Reactions

    Cephalosporins, including Fetroja, have been implicated in triggering CNS adverse reactions such as seizures. Encephalopathy, coma, asterixis, and neuromuscular excitability have been reported with cephalosporins, particularly in patients with a history of epilepsy and/or when recommended dosages of cephalosporins were exceeded due to renal impairment. Adjust Fetroja dosing based on creatinine clearance. If focal tremors or seizures occur, evaluate patients to determine whether Fetroja should be discontinued.

     

    Development of Drug-Resistant Bacteria

    Prescribing Fetroja in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.

     

    ADVERSE REACTIONS

    The most common adverse reactions occurring in ≥2% of patients receiving Fetroja in the cUTI trial were: diarrhea (4%), infusion site reactions (4%), constipation (3%), rash (3%), candidiasis (2%), cough (2%), elevations in liver tests (2%), headache (2%), hypokalemia (2%), nausea (2%), and vomiting (2%). The most common adverse reactions occurring in ≥4% of patients receiving Fetroja in the HABP/VABP trial were: elevations in liver tests (16%), hypokalemia (11%), diarrhea (9%), hypomagnesemia (5%), and atrial fibrillation (5%).

     

    Please click here for Full U.S. Prescribing Information for Fetroja® (cefiderocol).

     

    Forward-Looking Statements 

    This announcement contains forward-looking statements. These statements are based on expectations in light of the information currently available, assumptions that are subject to risks and uncertainties which could cause actual results to differ materially from these statements. Risks and uncertainties include general domestic and international economic conditions such as general industry and market conditions, and changes of interest rate and currency exchange rate. These risks and uncertainties particularly apply with respect to product-related forward-looking statements. Product risks and uncertainties include, but are not limited to, completion and discontinuation of clinical trials; obtaining regulatory approvals; claims and concerns about product safety and efficacy; technological advances; adverse outcome of important litigation; domestic and foreign healthcare reforms and changes of laws and regulations. Also for existing products, there are manufacturing and marketing risks, which include, but are not limited to, inability to build production capacity to meet demand, lack of availability of raw materials and entry of competitive products. The company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. 

     

    For Further Information, Contact:

    SHIONOGI Website Inquiry Form: https://www.shionogi.com/global/en/contact.html

    U.S. Media: ShionogiCommunications@shionogi.com

    Shionogi Europe Press Office: pressoffice@shionogi.eu

    Continue Reading

  • Japan parliamentary vote, Australia rare earth shares rise

    Japan parliamentary vote, Australia rare earth shares rise

    TOKYO, JAPAN – JULY 27: Pedestrians and shoppers walk through the Akihabara area on July 27, 2023 in Tokyo, Japan. Japan’s core consumer price index climbed by 3.3% in June, outpacing the US figure for the first time in eight years as the Bank of Japan holds its monetary policy meeting on July 27 and 28. (Photo by Tomohiro Ohsumi/Getty Images)

    Tomohiro Ohsumi | Getty Images News | Getty Images

    Japan’s benchmark Nikkei 225 rose more than 1% to a fresh record at 49,739.76, after closing at an all-time high Monday. The Topix also added 0.48% to hit a record high.

    Broader Asia-Pacific markets also opened higher, tracking Wall Street gains led by a rally in Apple shares.

    Investors await Japan’s parliamentary vote, which is likely to see Sanae Takaichi become the country’s next prime minister, after the right-wing opposition Japan Innovation Party said Monday it was ready to back her premiership.

    Australia’s ASX/S&P 200 rose 0.50%. Shares of the country’s rare earth companies rose after Prime Minister Anthony Albanese and U.S. President Donald Trump signed a critical minerals agreement Tuesday, aimed at countering China’s dominance.

    Australia’s Lynas Rare Earths added 3.8%, Iluka Resources jumped nearly 6%, Pilbara Minerals rose 4.7%. VHM skyrocketed over 30%, while Northern Minerals soared nearly 15%.

    South Korea’s Kospi index jumped 1.57%, while the small-cap Kosdaq gained 0.52%.

    Futures for Hong Kong’s Hang Seng Index pointed to a higher open, trading at 26,232, against the index’s previous close of 25,858.83.

    Indian markets are closed for a holiday.

    U.S. equity futures were little changed in early Asian hours, ahead of a busy earnings week from big-name companies and inflation data.

    Overnight, the three key benchmarks in the U.S. rose on a rally in Apple shares after Loop Capital upgraded it to buy from hold.

     The Dow Jones Industrial Average closed 515.97 points, or 1.12%, higher at 46,706.58. The S&P 500 also climbed 1.07% to settle at 6,735.13, while the Nasdaq Composite advanced 1.37% to settle at 22,990.54.

    — CNBC’s Sean Conlon and Pia Singh contributed to this report.

    Continue Reading

  • Venture Global ready to introduce natural gas into final part of Plaquemines LNG plant, filing shows – Reuters

    1. Venture Global ready to introduce natural gas into final part of Plaquemines LNG plant, filing shows  Reuters
    2. LNG Producer Faces Lawsuits Over Alleged Contract Breaches  Crude Oil Prices Today | OilPrice.com
    3. Fresh fight brewing between Venture Global and long-term customers  Upstream Online
    4. Pressure Mounts Against Venture Global to Start Commercial Service on Time at Plaquemines LNG  Natural Gas Intelligence
    5. Venture Global is facing new LNG contract scrutiny in Louisiana  10/12 Industry Report

    Continue Reading

  • DuPont Schedules Third Quarter 2025 Earnings Conference Call

    WILMINGTON, Del., Oct. 20, 2025 – DuPont (NYSE: DD) will release its third quarter financial results at 6:00 a.m. ET on Thursday, November 6, 2025. In addition, the company will host a conference call at 8:00 a.m. ET that day.

    The event will be webcast live and can be accessed on DuPont’s Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website.       

    The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5994046.

    DuPont will reflect the previously announced divestiture of its Aramids business as discontinued operations beginning with third quarter 2025 reporting and will reflect its electronics business, Qnity, as discontinued operations beginning in fourth quarter 2025 reporting following the intended separation of Qnity on November 1, 2025.

    Qnity expects to provide a business update on a separate conference call to be announced at a later date.

     

    About DuPont

    DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

    Continue Reading